A Randomized, Double-Blind, Placebo Controlled, Cross-over Study of the Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Multofocl Motor Neuropathy
- Registry ID
- EUCTR2009-013841-27
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Baxter Innovations GmbH
- Start date
- 2009-12-03
- Completion date
- 2011-08-11
- Last update
- 2026-08-16
Conditions
- Multifocal motor neuropathy
Summary
To evaluate the efficacy (effect on grip strength and disability) and safety/tolerability of IGIV, 10% in subjects with multifocal motor neuropathy (MMN).
Locations
View on source registry